Amazon Web Services will launch an AI agent for scientific literature via a partnership with Wiley, a publisher of journals.
The announcement will be made at the AWS Life Sciences Symposium in New York on Tuesday. The AWS conference will feature a bevy of big name customers including Merck, AstraZeneca, Genentech, Pfizer and Johnson & Johnson.
AWS has been developing a horizontal approach to AI agents via Amazon Q, which has gained momentum and a story after re:Invent 2024. The collaboration with Wiley highlights how AWS wants to also take AI agents into various industries.
According to Wiley, the literature search agent is available as part of an AWS open source toolkit for healthcare and life sciences agents. AWS' toolkit has a catalog of starter agents and frameworks for building and orchestrating them. Use cases include biomarker discovery, clinical trial protocol generation and detailed content searches.
Here's a look at a sample agent for healthcare and life sciences from AWS.
Wiley and AWS said that full-text content from the publisher can be integrated into AWS' agent stack including Bedrock Agents.
More on AI agents:
- Agentic AI: Everything that’s still missing to scale
- BT150 zeitgeist: Agentic AI has to be more than an 'API wearing an agent t-shirt'
More on healthcare:
- AI agents aimed at healthcare, but data interoperability still a big issue
- How GE Healthcare is approaching generative AI, LLMs, and transformation
- BT150 Spotlight: Centurion Health's Johnny Wu on delivering healthcare in prisons
- BT150 Spotlight: MultiCare Health System's Laurie Wheeler on optimization, change management and healthcare transformation
- BioNtech, InstaDeep bet on genAI models to advance R&D, drug discovery, cancer treatment
- AI 15O's Matt Lewis on GenAI adoption, psychology and life sciences
- Welldoc Chief AI Officer Anand Iyer on AI, data and healthcare transformation
- How ResMed’s data prowess sets it up for AI, sleep health market expansion
